Chester County News and Community Website
WILMINGTON, DE — Ashland Inc. (NYSE: ASH)recently launched a pharmaceutical excipient designed to improve the manufacturing and oral delivery of peptides and other low-permeability drugs, positioning the specialty chemicals company …
Ashland Targets Oral GLP-1 Market With New Drug Excipient Read More
WASHINGTON, D.C. — Medicare beneficiaries could soon gain significantly cheaper access to certain weight-loss and diabetes-related medications under a new federal demonstration program that will cap some monthly GLP-1 prescription …
Medicare to Cap Some GLP-1 Drug Costs at $50 for Seniors Read More
WASHINGTON, D.C. — Federal regulators are proposing new limits on the compounding of several widely used diabetes and weight-loss drugs, a move that could reduce access to lower-cost alternatives when …
FDA Moves to Restrict Compounded Weight-Loss Drugs Read More
HARRISBURG, PA — Attorney General Dave Sunday has issued a warning to Pennsylvanians about the risks of counterfeit GLP-1 receptor agonist drugs, which are widely used for managing diabetes and …
Counterfeit GLP-1 Drugs Threaten Lives: Urgent Warning for Pennsylvanians Read More